skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: assunto: Life Sciences & Biomedicine remover assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Evidence Suggesting That Obesity Prevention Measures May Improve Prostate Cancer Outcomes Using Data from a Prospective Randomized Trial
Evidence Suggesting That Obesity Prevention Measures May Improve Prostate Cancer Outcomes Using Data from a Prospective Randomized Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evidence Suggesting That Obesity Prevention Measures May Improve Prostate Cancer Outcomes Using Data from a Prospective Randomized Trial

Chandra, Ravi A. ; Chen, Ming-Hui ; Zhang, Danjie ; Loffredo, Marian ; D’Amico, Anthony V. Ornstein, David K.

Prostate Cancer, 2014-01, Vol.2014 (2014), p.478983-6 [Periódico revisado por pares]

Egypt: Hindawi Limiteds

Texto completo disponível

Citações Citado por
2
Targeting HIF-2 Alpha in Renal Cell Carcinoma
Targeting HIF-2 Alpha in Renal Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting HIF-2 Alpha in Renal Cell Carcinoma

Ahmed, Ramsha ; Ornstein, Moshe C.

Current treatment options in oncology, 2023-09, Vol.24 (9), p.1183-1198 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
3
Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook
Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook

Gopalakrishnan, Dharmesh ; Koshkin, Vadim S ; Ornstein, Moshe C ; Papatsoris, Athanasios ; Grivas, Petros

Therapeutics and clinical risk management, 2018-01, Vol.14, p.1019-1040 [Periódico revisado por pares]

New Zealand: Dove Medical Press Limited

Texto completo disponível

Citações Citado por
4
Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to Date
Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to Date
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to Date

Sheng, Iris Y ; Ornstein, Moshe C

Cancer management and research, 2020-01, Vol.12, p.4871-4881 [Periódico revisado por pares]

New Zealand: Dove

Texto completo disponível

Citações Citado por
5
The Immunotherapy Landscape in Renal Cell Carcinoma
The Immunotherapy Landscape in Renal Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Immunotherapy Landscape in Renal Cell Carcinoma

Brown, Landon C. ; Desai, Kunal ; Zhang, Tian ; Ornstein, Moshe C.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2020-12, Vol.34 (6), p.733-748 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
6
Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma
Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma

Koshkin, Vadim S ; Barata, Pedro C ; Zhang, Tian ; George, Daniel J ; Atkins, Michael B ; Kelly, William J ; Vogelzang, Nicholas J ; Pal, Sumanta K ; Hsu, JoAnn ; Appleman, Leonard J ; Ornstein, Moshe C ; Gilligan, Timothy ; Grivas, Petros ; Garcia, Jorge A ; Rini, Brian I

Journal for immunotherapy of cancer, 2018-01, Vol.6 (1), p.9-9, Article 9 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
7
Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target
Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target
Material Type:
Artigo 		Adicionar ao Meu Espaço

Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target

Koshkin, Vadim S ; Garcia, Jorge A ; Reynolds, Jordan ; Elson, Paul ; Magi-Galluzzi, Cristina ; McKenney, Jesse K ; Isse, Kumiko ; Bishop, Evan ; Saunders, Laura R ; Balyimez, Aysegul ; Rashid, Summya ; Hu, Ming ; Stephenson, Andrew J ; Fergany, Amr F ; Lee, Byron H ; Haber, Georges-Pascal ; Dowlati, Afshin ; Gilligan, Timothy ; Ornstein, Moshe C ; Rini, Brian I ; Abazeed, Mohamed E ; Mian, Omar Y ; Grivas, Petros

Clinical cancer research, 2019-01, Vol.25 (1), p.210-221 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
8
Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors
Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors

Gul, Anita ; Stewart, Tyler F ; Mantia, Charlene M ; Shah, Neil J ; Gatof, Emily Stern ; Long, Ying ; Allman, Kimberly D ; Ornstein, Moshe C ; Hammers, Hans J ; McDermott, David F ; Atkins, Michael B ; Hurwitz, Michael ; Rini, Brian I

Journal of clinical oncology, 2020-09, Vol.38 (27), p.3088-3094 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
9
Addition of Salvage Immunotherapy to Targeted Therapy in Patients with Metastatic Renal Cell Carcinoma
Addition of Salvage Immunotherapy to Targeted Therapy in Patients with Metastatic Renal Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Addition of Salvage Immunotherapy to Targeted Therapy in Patients with Metastatic Renal Cell Carcinoma

Dawsey, Scott J ; Ornstein, Moshe C

Current oncology (Toronto), 2021-11, Vol.28 (6), p.5019-5024 [Periódico revisado por pares]

Switzerland: MDPI

Texto completo disponível

Citações Citado por
10
Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor
Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor
Material Type:
Artigo 		Adicionar ao Meu Espaço

Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor

Ornstein, Moshe C. ; Wood, Laura S.

Advances in therapy, 2023-09, Vol.40 (9), p.3599-3609 [Periódico revisado por pares]

Cheshire: Springer Healthcare

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Assunto 

  1. Humans  (67)
  2. Male  (40)
  3. Female  (34)
  4. Immunotherapy  (25)
  5. Aged  (23)
  6. Urology & Nephrology  (22)
  7. Metastasis  (22)
  8. Middle Aged  (21)
  9. Kidney Cancer  (21)
  10. Tumors  (20)
  11. Adult  (19)
  12. Cancer  (17)
  13. Medical Sciences  (17)
  14. Biological And Medical Sciences  (17)
  15. Patients  (16)
  16. Medicine  (16)
  17. Medicine & Public Health  (15)
  18. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2002  (9)
  2. 2002Até2006  (8)
  3. 2007Até2012  (11)
  4. 2013Até2018  (24)
  5. Após 2018  (46)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.